YourLawyer.com® 1-800-LAW-INFO (1-800-529-4636)

Parker Waichman Alonso LLP Headlines by Topic

Procrit

Proposed Aranesp, Epogen, Procrit Dosage Limit Rejected by FDA Advisory Panel

Sep 12, 2007 | Parker Waichman Alonso, LLP
An advisory panel has concluded that Amgen's anemia medications should not be subject to a new dosage limit proposed by the Food & Drug...

Controversy over Aranesp, Epogen and Procrit to Be Addressed by FDA Panel

Sep 10, 2007 | Parker Waichman Alonso, LLP
Aranesp, Epogen and Procrit, drugs given to anemia patients suffering end-stage kidney failure, will be taken up by a Food & Drug Administration...

FDA Panel Highlights Safety Concerns of Anemia Drugs in Cancer Patients

May 11, 2007 | Newsinferno.com
In a high-profile meeting this week, an expert panel of the U.S. Food and Drug Administration (FDA) raised significant concerns about the use of the...

FDA panel wants more anemia drug studies

May 10, 2007 | AP
Two months after federal regulators ordered additional warnings be added to the labels of blockbuster anemia drugs, government advisers said Thursday...

FDA issues new warnings on anemia drugs

Mar 9, 2007 | AP
Federal health officials issued stern new warnings Friday for doctors to more carefully prescribe widely used anemia drugs that can increase the risk...

FDA Strengthens Safety Information for Erythropoiesis-Stimulating Agents (ESAs)

Mar 9, 2007 | www.fda.gov
The U.S. Food and Drug Administration (FDA) today issued a public health advisory outlining new safety information, including revised product...

FDA Warns of Serious Side Effects Related to Popular Anemia Drugs

Mar 9, 2007 | NewsInferno.com
FDA Warns of Serious Side Effects Related to Popular Anemia DrugsThe U.S. Food and Drug Administration (FDA) has issued a new warning about...

Anemia Drugs Procrit & Epogen May Do More Harm Than Good

Nov 30, 2006 | Newsinferno.com
Two studies in the New England Journal of Medicine this month have called into question the overuse of drugs in the treatment of anemia in kidney...

Page 3/3 [first] [prev] 1 2 3 [next] [last]

Defective Drugs
* Denotes required field.

Title

* First Name

* Last Name

* Email Address

* Phone Number

Cell Phone Number

Office Phone Number

Street Address

Apartment/Suite

City

State

Zip Code

Please provide the best method and times to contact you:

Date of birth of person injured
(mm-dd-yyyy):

Name of drug:

Date you started taking the drug (mm-yyyy):

Date you stopped taking the drug (mm-yyyy):

Please describe any side effects:

Other Info:

No Yes, I agree to the Parker Waichman Alonso LLP disclaimers.Click here to review all.

Yes, I would like to receive the Parker Waichman Alonso LLP monthly newsletter, InjuryAlert.

please do not fill out the field below.

Home | Defective Drugs | Medical Devices | Toxic Substances | Accidents | Product Liability | Malpractice | Diseases
Nursing Home Negligence | Food Poisoning | Other Topics | Social Security Disability | Contact
Statement of Clients' Rights | Site Map | Drug Injury Search | Vioxx | Mesothelioma | Permax | Dostinex | Composix Kugel Mesh X Large Patch
Ortho Evra | Fosamax | Personal Injury Lawyer | Fusarium Keratitis | Stevens Johnson Syndrome | Florida Personal Injury Law Firm

© 2002-2009 YourLawyer.com®. All Rights Reserved.

Please note that you are not considered a client until you have signed a retainer agreement and your case has been accepted by us.
Prior results do not guarantee or predict a similar outcome with respect to any future matter.
Attorney Advertising

Parker Waichman Personal Injury News